← Back to All Filings

Lilly Endowment Sells $176M in LLY Stock in Routine Transaction

Low SignificanceNovember 20, 2025 at 4:03:07 PM EST

ELI LILLY & Co

$LLY4CIK: 0000059478

Subscribe to track LLY

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Lilly Endowment Sells $176M in LLY Stock in Routine Transaction

Company: ELI LILLY & Co (LLY) Form: 4 | Filed: 2025-11-20 Significance: Low

Insider: LILLY ENDOWMENT INC Relationship: 10% Owner

Transaction: • Type: Sale • Shares: 167,526 • Avg. Price: $1,051.25 • Value: $176,111,506 • Owned After: 92,644,452

Key Insight: Despite the large dollar value, this sale represents a negligible fraction (0.019%) of Eli Lilly's market cap and a tiny portion of the Endowment's total holdings, indicating a routine portfolio adjustment rather than a significant strategic shift.

This is PUBLIC SEC data for educational purposes. Not investment advice.

Comprehensive Analysis

SEC Filing Analysis: ELI LILLY & Co (LLY)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: Lilly Endowment Inc., a major shareholder, sold $176.1 million worth of Eli Lilly stock, a transaction that is immaterial relative to the company's nearly trillion-dollar market capitalization and the Endowment's vast holdings.
  • Market Impact: The sale is too small to have a meaningful impact on the stock, representing only 0.018% of shares outstanding.

Company Information

FieldValue
CompanyELI LILLY & Co
Ticker SymbolLLY
CIK0000059478
IndustryPharmaceutical Preparations

Insider Information

FieldValue
NameLILLY ENDOWMENT INC
CIK0000316011
Title/Positionnull
Relationship10% Owner

Transaction Details

FieldValue
Form Type4
Transaction Date2025-11-19
Transaction CodeS (Sale)
Security TypeCommon Stock
Shares Involved167,526
Price Per Share$1,051.25 (Weighted Avg.)
Total Value$176,111,506
Shares Owned After92,644,452
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$176,111,506
% of Market Cap0.019%
Shares Transacted167,526
% of Shares Outstanding0.018%
Post-Transaction Ownership92,644,452 shares (9.79% of outstanding)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: For a mega-cap company like Eli Lilly with a market capitalization of $917.64 billion, a $176 million transaction is financially insignificant.
  • Ownership Concentration: The sale represents a minuscule reduction (approx. 0.18%) in the Endowment's total position. Their ownership remains substantial at 9.79% of all outstanding shares, indicating continued long-term alignment.
  • Transaction Significance: The sale falls well below the thresholds for moderate or high significance. It is likely part of the Endowment's regular, pre-planned diversification or liquidity generation strategy, as is common for large foundations.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The transaction size is negligible compared to the company's market value and the stock's daily trading volume. It does not signal a change in the insider's fundamental outlook.

Volume & Sentiment

  • Expected Volume Impact: Minimal. The number of shares is unlikely to cause a noticeable impact on trading volume.
  • Sentiment Indicator: Neutral. This is a routine transaction by a large institutional holder, not a signal of changing sentiment.

Additional Context

Transaction Notes

  • Special Circumstances: The sales occurred across multiple transactions at weighted average prices, as detailed in the filing's footnotes. This is typical for large block sales to minimize market impact.
Topics:#SECFiling#InsiderTrading#LLY#EliLilly#Form4#InsiderSell#LillyEndowment#StockMarket#MarketAnalysis

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.